New program aims to cut unnecessary pills for dementia patients
NCT ID NCT04938648
First seen Jun 22, 2026 · Last updated Jun 22, 2026
Summary
This study tested a program where a pharmacist worked with people living with dementia, their care partners, and their doctors to review and reduce unnecessary medications. The goal was to simplify medication routines and lower treatment burden. The study included 138 participants aged 65 and older with dementia and multiple chronic conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE AND RELATED DEMENTIAS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
-
Kaiser Permanente
Aurora, Colorado, 80014, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pharmacist-led deprescribing intervention (educational materials, telehealth visit, and provider communication)
What this could lead to
If successful, this approach could help people with dementia take fewer unnecessary medications, reducing side effects and simplifying daily care.
What could go wrong
This is a small feasibility study, not a large trial. The program may not work for everyone, and deprescribing must be done carefully to avoid withdrawal risks.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.